Referenzen
Produkte Transfektion
Kostenlose Testsamples
Anwendungshinweise:
Im „Transfection Reagent Selection Guide“ können Sie durch Filterfunktionen z.B. für Ihre Kombination aus zu transfizierender Zelle und Nukleinsäure die Liste vorhandener Referenzen durchsuchen. Ebenso können Sie im Feld „Referenzen durchsuchen“ am Anfang der Seite mit passenden Schlagwörtern zu einem Ergebnis gelangen. Eine Referenz zeigt an, dass das gefundene Transfektionsreagenz bereits erfolgreich für die entsprechende Anwendung verwendet wurde. Im Idealfall sind getestete Transfektionsparameter und Transfektionseffizienzen angegeben.
Keine Referenz? > Allgemeine Auswahlhilfe
Wenn Sie keine Referenz gefunden haben, heißt das nicht, dass kein passendes Reagenz zur Verfügung steht, sondern lediglich, dass bisher keine Erfahrungsberichte vorliegen. In diesem Falle kann durch eine Vorauswahl ein erfolgsversprechendes Transfektionsreagenz ausgewählt (Allgemeine Auswahlhilfe) und letztendlich ausgetestet (Kostenlose Testsamples) werden. Wenn Sie einen Erfahrungsbericht für uns schreiben möchten machen wir Ihnen ein Angebot für eine Gegenleistung.
CELL TYPE | DESCRIPTION OF CELL TYPE | CAT.NO. | SPECIES | ORIGIN OF CELLS | COMMON CELL TYPE | GROWTH PROPERTIES | NUCLEIC ACID / DELIVERED MOLECULE | APPLICATION | PRODUCT | REFERENCE TYPE | BIBLIOGRAPHIC DATA | LINK | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Daoy |
Human desmoplastic cerebellar medulloblastoma cell line | ATCC HTB-186 | Human | brain | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | M.C. Burger et al., Int. J. of Oncology, 2012, 41: 235-241, DOI: 10.3892/ijo.2012.1446 | Link | |
DG-75 |
Human Burkitt's lymphoma cell line | ATCC CRL-2625 | Human | immune system | cell line | suspension | plasmid | Metafectene | publication | S. Thakker et al., J. Virol., May 2015; 89: 5536 - 5556 | |||
DLD-1 |
Human colon adenocarcinoma cell line | ATCC CCL-221 | Human | digestive organs | cell line | adherent | plasmid | CRISPR | Metafectene | publication | C. Emming, Dissertation, 2021, Ludwig-Maximilians-Universität München | Link | |
DLD-1 |
Human colon adenocarcinoma cell line | ATCC CCL-221 | Human | digestive organs | cell line | adherent | plasmid | Metafectene PRO | publication | M. Masià-Balagué et al., J. Biol. Chem., Jun 2015; 290: 15197 - 15209 | |||
DLD-1 |
Human colon adenocarcinoma cell line | ATCC CCL-221 | Human | digestive organs | cell line | adherent | plasmid | stable transfection | Metafectene | publication | C. Emming, Dissertation, 2021, Ludwig-Maximilians-Universität München | Link | |
DU145 |
Human prostate cancer cell line, derived from metastatic site: brain | ATCC HTB-81 | Human | brain | cell line | adherent | plasmid | Metafectene | publication | V. Shoshan-Barmatz et al., 2014, US 8,648,045 (Patent) | Link | ||
DU145 |
Human prostate cancer cell line, derived from metastatic site: brain | ATCC HTB-81 | Human | brain | cell line | adherent | plasmid | Metafectene | publication | S.-B. Varda et al., 2012, EP 2 371 846 | Link | ||
DU145 |
Human prostate cancer cell line, derived from metastatic site: brain | ATCC HTB-81 | Human | brain | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | K. J. Choi et al., Cancer Res., Apr 2007; 67: 3654 - 3662 | Link | |
DU145 |
Human prostate cancer cell line, derived from metastatic site: brain | ATCC HTB-81 | Human | brain | cell line | adherent | plasmid | Metafectene PRO | publication | C. Morich, Dissertation, 2016, Georg-August University Göttingen | Link | ||
DU447 |
Human mammary adenocarcinoma cell line | Human | breast | cell line | iron oxide | Metafectene | publication | L. Matuszewski et al., Radiology, Apr 2005; 235: 155 - 161 | |||||
ECV-304 |
Human uroepithelial bladder carcinoma cell line | DSM ACC 310 | Human | urinary system | cell line | adherent | plasmid | Metafectene | publication | J. Pelisek et al., J Mol Med (Berl), Nov 2002; 80(11): 724-36 | |||
EFO-27 |
Human ovary adenocarcinoma cell line (cisplatin resistant) | Human | genital tract | cell line | adherent | plasmid | K2 Transfection System | publication | S. Dilruba et al., Cells, 2020, 9: 515, doi:10.3390/cells9020515 | Link | |||
EJ138 |
Human bladder carcinoma cell line | ECACC 85061108 | Human | urinary system | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | M.C. Burger et al., Int. J. of Oncology, 2012, 41: 235-241, DOI: 10.3892/ijo.2012.1446 | Link | |
F-IPF |
Human primary lung fibroblasts | Human | respiratory system | primary cell | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene EASY | publication | X. Deng et al., The Int. J. of Biochem. & Cell Biol., 213, 45: 1366– 1376, doi.org/10.1016/j.biocel.2013.04.003 | |||
F-NL |
Human primary lung fibroblasts | Human | respiratory system | primary cell | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene EASY | publication | X. Deng et al., The Int. J. of Biochem. & Cell Biol., 213, 45: 1366– 1376, doi.org/10.1016/j.biocel.2013.04.003 | |||
F26IIB |
Human cells derived from a dyskeratosis congenita patient | Human | unknown | unknown | plasmid | K2 Transfection System | publication | L. Iarriccio et al., PLOS ONE, 2015, DOI:10.1371/journal.pone.0142980 | Link | ||||
FG |
Human pancreatic adenocarcinoma cell line (Derivat of Colo357) | Human | digestive organs | cell line | adherent | plasmid | Metafectene | publication | H. Seeliger et al., Mol. Cancer Res., Feb 2009; 7: 189 - 198 | Link | |||
Flp-In 293 |
Human embryonic kidney cell line (derivative of HEK293) | Human | urinary system | cell line | adherent | plasmid | stable transfection | Metafectene | publication | S. M. Hoser et al., Genome Biology, 2020, 21: 299, doi.org/10.1186/s13059-020-02199-6 | Link | ||
Flp-In T-REx HeLa |
Human cervix adenocarcinoma cell line (derivative of HeLa) | Human | genital tract | cell line | adherent | plasmid | CRISPR | Metafectene PRO | publication | T. M. Nthiga et al., J. Cell Biol., 2021, 220, 6, doi.org/10.1083/jcb.202006128 | Link | ||
Flp-In T-REx HeLa |
Human cervix adenocarcinoma cell line (derivative of HeLa) | Human | genital tract | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | T. M. Nthiga et al., J. Cell Biol., 2021, 220, 6, doi.org/10.1083/jcb.202006128 | Link | ||
Flp-in TREx 293 |
Human embryonic kidney cell line (Derivat of HEK293) | Human | urinary system | cell line | adherent | plasmid | Metafectene PRO | publication | J. Birk et al., J. Cell Sci., Apr 2013; 126: 1604 - 1617 | Link | |||
Flp-in TREx 293 |
Human embryonic kidney cell line (derivative of HEK293) | Human | urinary system | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | T. M. Nthiga et al., The EMBO J., 39: e103649, DOI 10.15252/embj.2019103649 | Link | ||
Flp-in TREx 293 |
Human embryonic kidney cell line (Derivat of HEK293) | Human | urinary system | cell line | adherent | plasmid | CRISPR | Metafectene PRO | publication | B. K. Shrestha et al., J. Biol. Chem., 2019,doi/10.1074/jbc.RA119.010068 | Link | ||
Flp-in TREx 293 |
Human embryonic kidney cell line (derivative of HEK293) | Human | urinary system | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | B.K. Shrestha et al., J Biol Chem., 2020, 295(5): 1240–1260, doi: 10.1074/jbc.RA119.010068 | Link | ||
Flp-in TREx 293 |
Human embryonic kidney cell line (Derivat of HEK293) | Human | urinary system | cell line | adherent | plasmid | Metafectene PRO | publication | T. Ramming, Dissertation, 2014, Universitaet Basel | Link |